FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4


The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure….

Seizing the Opportunity to “End the Scourge of HIV/AIDS

Richard J. Wolitski, Ph.D., Acting Director, Office of HIV/AIDS and Infectious Disease Policy, HHS

“Right now, we’re on track to end the scourge of HIV/AIDS. That’s within our grasp.”—President Barack Obama The power of those words really struck me when I heard President Obama say them in his final State of the Union address last week. I’ve wanted to believe that this was possible for the 30 years I’ve been…

ICYMI – NIH’s Dr. Anthony Fauci Pens Op-Ed on Tools to End HIV/AIDS


In case you missed it, last week Dr. Anthony Fauci shared an op-ed in The Washington Post: “No more excuses. We have the tools to end the HIV/AIDS pandemic.” Dr. Fauci, Director of the National Institute of Allergy and Infectious Diseases at NIH, observes, “[W]hy does this global pandemic continue to rage? It is not…

NIH Image Gallery Now on Flickr

NIH Image Gallery

Editor’s Note: Our first new media blog of 2015 emphasized the value of “keeping it visual.” So for our final new media post for the year, we share with you an image gallery from the National Institutes of Health that can help enhance your digital content. Looking for health or science related images? The National Institutes…

FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply


Today, the U.S. Food and Drug Administration issued final guidance outlining updated blood donor deferral recommendations to reflect the most current scientific evidence and to help ensure continued safety of the blood supply by reducing the risk of human immunodeficiency virus (HIV) transmission by blood and blood products. “The FDA’s responsibility is to maintain a…

National HIV Prevention Conference: Day 1 Recap


What Did You Miss? Thousands of attendees from around the country are in Atlanta, Georgia this week to attend the 2015 National HIV Prevention Conference. For those who are not able to attend, check out daily conference highlights: Sunday, December 6th The opening plenary of CDC’s National HIV Prevention Conference (NHPC) drew over 3,000 scientists,…

National HIV/AIDS Strategy in the Spotlight at 2015 National HIV Prevention Conference

Ronald Valdiserri

The CDC’s 2015 National HIV Prevention Conference got underway last evening in Atlanta. Dr. Jonathan Mermin, MD, Director of CDC’s National Center for HIV, Viral Hepatitis, STD and TB Prevention, welcomed the more than 3,000 participants who have gathered under the conference theme of “Accelerating Progress: Prevent Infections. Strengthen Care. Reduce Disparities.” The opening plenary…

White House World AIDS Day Observance Features Release of National HIV/AIDS Strategy Federal Action Plan

Valdiserri - Dec 4 blog

The White House hosted a World AIDS Day observance on Tuesday, December 1, 2015, welcoming domestic and global leaders in the fight against HIV/AIDS. Gathered under the theme “The time to act is now,” various presenters highlighted key actions underway or about to begin here in the U.S. and around the globe. The event opened…